Advertisement

40th NRL Workshop on Infectious Disease Testing

Park Hyatt Melbourne 1 Parliament Square, Melbourne, VIC, Australia

Australia's 40th NRL Workshop on Infectious Disease Testing will be held 7-9 October in Melbourne Explore a comprehensive lineup of expert speakers and insightful sessions, covering the latest advancements infectious diseases. Highlighted agenda topics include: Evaluation of the Roche Cobas HIV-1/HIV-2 Qualitative assay for the diagnosis of HIV-1 The Role of Diagnostics to Support Reaching

The Changing DEI Legislation and Policy Landscape and Its Impact on Health and Public Health’s Workforce

Keck Center 500 5th Street Northwest, Washington, DC, United States
Hybrid Hybrid Event

The National Academies Roundtable on the Promotion of Health Equity will host a public hybrid workshop on October 9, 2024 in Washington, DC to explore the impact of DEI legislation and policies on achieving a diverse health care and public health workforce. Following the June 2023 Supreme Court ruling against affirmative action in colleges and

Review of CDC COVID-19 Vaccine Safety Research and Communications Meeting 3

Virtual Event Virtual Event

The Committee to Review the CDC's COVID-19 Vaccine Safety Research and Communications will host a two-hour public comment session on 11 October 2024. Pre-registered attendees will have the opportunity to provide virtual public comments and suggestions on how to improve CDC’s vaccine safety research, and how to make vaccine safety and risk information better and

Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1)

Virtual Event Virtual Event

The National Academies of Sciences, Engineering, and Medicine will organize a public workshop  on the Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1) from 22-23 October 2024 via webcast. The workshop discussions may help inform future research that could provide local, national, and global communities with information about

A Long COVID Diagnosis: Implications for Social, Behavioral, and Economic Sciences

Virtual Event Virtual Event

A Long COVID diagnosis has far-reaching impacts on individuals and communities. While most people recover fully from COVID-19, tens of millions continue to experience debilitating symptoms that affect their daily lives, including persistent fatigue, cognitive challenges, and social isolation. As these challenges persist, it is crucial to understand and address the social and behavioral dimensions

Pandemic Preparedness: Achievements, Current Challenges, and New Frontiers

Savoia Excelsior Palace Riva del Mandracchio, Trieste, Italy

The Pandemic Preparedness: Achievements, Current Challenges, and New Frontiers conference will be held 11-13 November 2024 in Trieste, Italy. Join world-renowned scientists discussing the known and emerging viruses representing a potential epidemic risk. The event will focus on prevention, surveillance, detection, drug discovery, treatment, and cooperation, to tackle challenges and implementing response strategies related to

ASTMH 2024 – American Society of Tropical Medicine & Hygiene

Ernest N. Morial New Orleans Convention Center 900 Convention Center Blvd, New Orleans, LA, United States

The American Society of Tropical Medicine & Hygiene will host the ASTMH 2024 Annual Meeting from 13-17 November 2024 in New Orleans, Louisiana. The meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students, and all healthcare providers working in the fields of

Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors

Virtual Event Virtual Event

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors. In this workshop, FDA will convene a panel of external experts to